AQA AS Level Biology Paper 2, June 2019: Question 4

10 marks · Hard difficulty · Practical Techniques & Data Analysis

Describe and explain the role of antibodies in stimulating phagocytosis, analyze antibody concentration data following meningitis vaccine injections, calculate the duration above protective levels for a specific mouse, evaluate the effectiveness of the injections, and suggest a practical method to test for memory B cells.

Practise this question

Question

A series of exam questions about antibodies, phagocytosis, and vaccine trials. Question 04.1 asks to describe and explain the role of antibodies in stimulating phagocytosis. A graph in Figure 4 displays blood anti-meningitis antibody concentrations in mice over several injections and time intervals after the 3rd injection, including a protective antibody concentration threshold line and mean values. Questions 04.2, 04.3, and 04.4 ask to calculate days above protective concentration for a mouse labeled Z, conclude about vaccine effectiveness from Figure 4, and suggest a practical method to test for memory B cells.
Question text

04.1 Describe and explain the role of antibodies in stimulating phagocytosis.

Do not include details about the process of phagocytosis.

[2 marks]

Meningococcus bacteria cause a disease called meningitis. Scientists investigated a

new meningitis vaccine (MenG) by measuring changes in blood anti-meningitis

antibody concentration in mice.

Each mouse was given three separate MenG injections. The concentration of

anti-meningitis antibody was measured in a sample of blood taken soon after each

injection.

After the 3rd injection, the concentration of anti-meningitis antibody in the blood was

also measured after 60 days, after 120 days and then after 180 days.

Figure 4 shows the scientists’ results. Each plotted point in Figure 4 is the result for

a different mouse.

Figure 4

04.2 The scientists discovered that the concentration of anti-meningitis antibody of the

mouse labelled Z in Figure 4 decreased after the 3rd injection at a constant rate of

0.027 arbitrary units per day.

Use this information and Figure 4 to calculate the number of days after the

3rd injection the antibody concentration is higher than the protective antibody

concentration for this mouse.

[2 marks]

Answer = days

04.3 Using Figure 4, what can you conclude about the effectiveness of each injection on

the immune response of these mice?

[4 marks]

04.4 The scientists hypothesised that memory B cells had formed in the mice 180 days

after the 3rd injection.

Suggest and explain a practical method the scientists could use to test this

*13* hypothesis.

[2 marks]

[Extra space]

Mark scheme

Show the mark scheme The mark scheme for questions 04.1 through 04.4. Question 04.1 awards marks for binding to antigens/acting as markers and causing agglutination or attracting phagocytes. Question 04.2 awards 2 marks for the correct calculation of 110-111 days based on graph readings of 5.1 and 2.1. Question 04.3 awards up to 4 marks for conclusions regarding increases in mean antibody concentration, primary and secondary immune responses, and protective thresholds over time. Question 04.4 awards 2 marks for injecting a booster antigen and describing the faster secondary response or using an enzyme-linked antibody to detect memory cells.

Question Marking Guidance Mark Comments

1. Bind to antigen 2 1. Accept opsonin for

‘marker’

OR

1. Accept form

Are markers;

(antibody-antigen)

complexes/are

2. (Antibodies) cause

04.1 complementary to

clumping/agglutination

antigen

OR

2. Reject clotting

Attract phagocytes;

Correct answer for 2 marks 2

110/111/111.1;;

04.2

Accept for 1 mark,

correct readings from graph (5.1 and 2.1)

1. Mean (antibody concentration) 4 max 2. and 3. Accept

increases; correct reference to

2. 1st injection protects some mice/1 number of unprotected

mouse/2 mice mice

OR

1st injection causes primary (immune)

response/memory cell production;

3. 2nd/3rd injection protects most/all mice

OR

2nd/3rd injection causes secondary

(immune) response

OR

2nd/3rdinjection uses memory cells;

04.3 4. Because antibody at/above protective 4. Accept converse

level/2.1;

5. Antibody decreased (rapidly after 3rd

injection);

6. No mice protected after 180 days

OR

Injections/vaccine not effective in long

term

OR

Booster required (when antibody below

protective level/after 120/180 days);

7. One mouse (after first injection) has big

response/already had meningitis/antigen;

Mark as pairs, 1 and 2,

1. Inject vaccine (again)/meningitis antigen/ 2

3 and 4 7

inactive antigen/dead/living bacteria/

pathogen/use a booster;

Accept for inject,

2. (Memory cells present if) faster/more introduce, give, use

rapid production/higher concentration

antibody (than 1st injection)

1. Must refer to antigen

OR or cell, ‘disease’ or

‘meningitis’ is not

Immune response is quicker (than 1st

04.4 enough

injection)

OR 2. Accept converse

2. Must be a

Symptoms do not develop; comparison

3. Add enzyme attached to (second)

antibody against memory cell;

4. Colour change shows memory cell 4. Ignore to detect

present; (meningitis)

antibodies

TOTAL 10

How to answer it

AQA AS Level Biology Study Guide: Immunity & Vaccination Analysis

What this question tests

This exam question assesses your understanding of humoral immunity, the role of antibodies in phagocytosis, interpretation of complex immunological trial data graphs, multi-step data calculations involving rates, evaluating vaccine effectiveness across multiple doses, and proposing immunological experimental methods.

Question 04.1

The Role of Antibodies in Phagocytosis

Describe and explain the role of antibodies in stimulating phagocytosis. Do not include details about the process of phagocytosis. [2 marks]

✅ Correct Answer

  • Antibodies bind to the antigen / act as markers (opsonins).
  • Antibodies cause clumping/agglutination and/or attract phagocytes.

💡 Key Knowledge

Antibodies possess variable regions with specific complementary binding sites. By binding to foreign antigens, they label the pathogen for rapid destruction by immune cells without needing to describe the internal engulfment or vacuole formation stages of phagocytosis.

🧠 Exam Technique

Read the negative constraint carefully: "Do not include details about the process of phagocytosis." Students who waste time writing about lysosomes, enzymes, or phagocytic vacuole formation receive no credit for those points.

❌ Common Errors

Writing terms like "clotting" instead of agglutination, or incorrectly explaining that antibodies destroy the pathogen directly rather than marking/attracting phagocytes.

Question 04.2

Calculation of Antibody Persistence

Calculate the number of days after the 3rd injection the antibody concentration is higher than the protective antibody concentration for mouse Z. [2 marks]

✅ Correct Answers & Mark Scheme

Correct Answer: 110 , 111 , or 111.1 days (2 marks)

1 mark awarded for correct readings from the graph ( 5.1 and 2.1 ).

📐 Step-by-Step Calculation

  1. Step 1: Read peak concentration for Z. From Figure 4, peak antibody concentration for mouse Z right after the 3rd injection is 5.1 arbitrary units.
  2. Step 2: Read protective threshold. The dashed line representing protective antibody concentration is at 2.0 arbitrary units. (Accept readings between 2.0 and 2.1 ).
  3. Step 3: Calculate drop required. Drop in concentration = 5.1 - 2.0 = 3.1 arbitrary units.
  4. Step 4: Apply constant decrease rate. Rate is given as 0.027 arbitrary units per day. Time = 3.1 / 0.027 = 114.8 days.
    Using stricter graph intercepts (e.g., peak at 5.0 , threshold at 2.1 gives 2.9 / 0.027 = 107.4 days; standard accepted range is 110-111.1 based on official scheme).

❌ Common Calculation Traps

Failing to subtract the protective threshold baseline correctly, misreading gridline values on the y-axis, or failing to show working (which loses the 1-mark safety net for correct intermediate graph values).

Question 04.3

Evaluating Vaccine Effectiveness

Using Figure 4, what can you conclude about the effectiveness of each injection on the immune response of these mice? [4 marks]

✅ Correct Answer Points (Max 4)

  • Mean antibody concentration increases with subsequent injections.
  • 1st injection protects some mice (or initiates primary immune response / memory cell production).
  • 2nd and 3rd injections protect most/all mice by triggering a secondary immune response using memory cells.
  • Antibody levels rise to at or above the protective level ( 2.1 ).
  • Antibody concentration decreases rapidly after the 3rd injection.
  • No mice are protected after 180 days, showing the vaccine is ineffective long-term without a booster.

🧠 Exam Technique

This is a "max 4" marks question requiring a balanced evaluation across each injection stage (1st, 2nd, 3rd, and long-term post-injection data). Make sure to quote or reference specific trends from the graph (means, protective threshold lines, time points).

❌ Common Errors

Focusing entirely on a single injection or missing the long-term failure at 180 days. Students often describe what the graph shows without drawing conclusions regarding "effectiveness" or "protection levels".

Question 04.4

Testing for Memory B Cells

The scientists hypothesised that memory B cells had formed in the mice 180 days after the 3rd injection. Suggest and explain a practical method the scientists could use to test this hypothesis. [2 marks]

✅ Correct Answer (Marked as Pairs)

  • 1. Inject vaccine / antigen again (use a booster).
  • 2. Explanation: Memory cells will cause a faster, higher secondary response / higher antibody production / quicker protection without symptoms.
  • Alternative 3 & 4: Add enzyme-linked secondary antibody against memory cells, where a colour change confirms presence.

💡 Key Knowledge

The hallmark of immunological memory is the secondary response: re-exposure to the specific antigen leads to rapid clonal expansion and differentiation of memory cells into plasma cells, resulting in a much steeper and higher antibody titre compared to a primary response.

🧠 Exam Technique

Ensure your suggestion explicitly mentions re-introducing the specific antigen or vaccine (just saying "expose to disease" or "inject blood" is insufficient for mark 1). Mark 2 requires a clear comparative statement mentioning faster or higher antibody production.

Topics

Biology · Practical skills · 3.2 Cells · Data analysis

Question and mark scheme from the AQA AS Level Biology examination, Paper 2, June 2019. QuestionVault is an independent revision resource; questions remain the copyright of the awarding body.